ES443725A1 - Metodo para producir un producto hipotensor. - Google Patents

Metodo para producir un producto hipotensor.

Info

Publication number
ES443725A1
ES443725A1 ES443725A ES443725A ES443725A1 ES 443725 A1 ES443725 A1 ES 443725A1 ES 443725 A ES443725 A ES 443725A ES 443725 A ES443725 A ES 443725A ES 443725 A1 ES443725 A1 ES 443725A1
Authority
ES
Spain
Prior art keywords
compounds
radical
carbon atoms
stands
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES443725A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Publication of ES443725A1 publication Critical patent/ES443725A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
ES443725A 1974-12-20 1975-12-19 Metodo para producir un producto hipotensor. Expired ES443725A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB55209/74A GB1489879A (en) 1974-12-20 1974-12-20 N'-cyano-n'-3-pyridylguanidines

Publications (1)

Publication Number Publication Date
ES443725A1 true ES443725A1 (es) 1977-04-16

Family

ID=10473276

Family Applications (1)

Application Number Title Priority Date Filing Date
ES443725A Expired ES443725A1 (es) 1974-12-20 1975-12-19 Metodo para producir un producto hipotensor.

Country Status (22)

Country Link
US (2) US4057636A (en:Method)
JP (1) JPS6028819B2 (en:Method)
AT (1) AT346357B (en:Method)
BE (1) BE836885A (en:Method)
CA (1) CA1067083A (en:Method)
CH (1) CH618429A5 (en:Method)
DD (1) DD122529A5 (en:Method)
DE (2) DE2557438A1 (en:Method)
DK (1) DK145341C (en:Method)
ES (1) ES443725A1 (en:Method)
FI (1) FI60560C (en:Method)
FR (1) FR2294703A1 (en:Method)
GB (1) GB1489879A (en:Method)
IE (1) IE42141B1 (en:Method)
IT (1) IT1062213B (en:Method)
LU (1) LU74071A1 (en:Method)
NL (1) NL184109C (en:Method)
PH (1) PH12506A (en:Method)
SE (1) SE424637B (en:Method)
SU (1) SU683615A3 (en:Method)
YU (1) YU39754B (en:Method)
ZA (1) ZA757481B (en:Method)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562066A (en) * 1978-11-03 1980-05-10 Toshihiko Okamoto N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
US4490533A (en) * 1980-12-22 1984-12-25 Merck & Co., Inc. Aminoalkyl pyridine derivatives
IE52935B1 (en) * 1981-04-15 1988-04-13 Leo Pharm Prod Ltd Pharmaceutical preparation
IE54196B1 (en) * 1981-09-10 1989-07-19 Leo Pharm Prod Ltd Chemical compounds
DK58983D0 (da) * 1983-02-11 1983-02-11 Leo Pharm Prod Ltd Farmaceutisk praeparat
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US4617311A (en) * 1985-05-17 1986-10-14 Eli Lilly And Company Antiasthmatic method
GB8617623D0 (en) 1986-07-18 1986-08-28 Beecham Group Plc Treatment
EP0579260A1 (en) * 1987-07-07 1994-01-19 Beecham Group Plc Use of a vasodilator for the treatment of pulmonary hypertension and/or right heart failure-related conditions
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation
US5244664A (en) * 1988-01-21 1993-09-14 Leo Pharmaceutical Products Ltd. Topical preparation for treatment of alopecia
GB8801318D0 (en) * 1988-01-21 1988-02-17 Leo Pharm Prod Ltd Pharmaceutical preparations
WO1989010757A1 (en) * 1988-05-10 1989-11-16 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemis New ophthalmic preparation for treating glaucoma
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
US5278169A (en) * 1988-08-09 1994-01-11 E. R. Squibb & Sons, Inc. Method of treating or prevention of fibrillation of the heart
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
JP2884412B2 (ja) * 1988-10-21 1999-04-19 日本バイエルアグロケム株式会社 殺虫性シアノ化合物
IL93252A0 (en) * 1989-02-03 1990-11-29 Lilly Co Eli Improvements in and relating to guanidine derivatives
US5264445A (en) * 1989-02-03 1993-11-23 Eli Lilly And Company (-)-N"-cyano-N-3-pyridyl-N'-1,2,2-trimethylpropylguanidine
EP0407346A3 (en) * 1989-07-07 1991-10-02 Ciba-Geigy Ag Aminopyridines
US5006523A (en) * 1989-10-26 1991-04-09 E. R. Squibb & Sons, Inc. Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers
US5217982A (en) * 1990-09-25 1993-06-08 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive properties
US5371086A (en) * 1991-03-15 1994-12-06 The Green Cross Corporation Aminopyridine compounds
JPH05294935A (ja) * 1991-03-15 1993-11-09 Green Cross Corp:The アミノピリジン系化合物
FR2677019B1 (fr) * 1991-05-27 1994-11-25 Pf Medicament Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
US5593993A (en) * 1991-08-02 1997-01-14 Medivir Ab Method for inhibition of HIV related viruses
IL102548A (en) * 1991-08-02 1998-08-16 Medivir Ab Thiourea derivatives for use in the preparation of medicaments for the inhibition of hiv and the treatment of aids and some such novel compounds
EP0618798B1 (en) * 1991-12-23 1997-03-12 PHARMACIA & UPJOHN COMPANY Pyridylguanidine compounds for treatment of erectile dysfunction
US5262419A (en) * 1992-06-11 1993-11-16 E. R. Squibb & Sons, Inc. Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
AU4530693A (en) * 1992-08-13 1994-03-15 Upjohn Company, The Cyanoguanidines as potassium channel blockers
GB9219472D0 (en) * 1992-09-15 1992-10-28 Leo Pharm Prod Ltd Chemical compounds
JPH06228100A (ja) * 1992-12-07 1994-08-16 Green Cross Corp:The 光学活性アミノピリジン誘導体およびその用途
JPH08511264A (ja) * 1993-06-11 1996-11-26 ジ・アップジョン・カンパニー Ｋ−チャンネル遮断剤としてのピリミジン，シアノグアニジン
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
US5633374A (en) * 1993-11-26 1997-05-27 The Upjohn Company Pyrimidine, cyanoguanidines as K-channel blockers
AU1556695A (en) * 1994-01-28 1995-08-15 Pharmacia & Upjohn Company Cyanoguanidines as k-channel blockers
US5525742A (en) * 1994-06-10 1996-06-11 The Upjohn Company Azidophenylcyanoguanidines as photoaffinity probes
US5856449A (en) * 1994-11-17 1999-01-05 Pharmacia & Upjohn Company Protein affecting KATP channels
WO1998006399A1 (en) * 1996-08-15 1998-02-19 Smithkline Beecham Corporation Il-8 receptor antagonists
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
US6458835B2 (en) 1997-08-13 2002-10-01 Bristol-Myers Squibb Company Method of inhibiting or treating chemotherapy-induced hair loss
US6013668A (en) 1997-08-13 2000-01-11 Bristol-Myers Squibb Company Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino]methyl]amino]benzonitrile
WO1999011621A2 (en) * 1997-09-03 1999-03-11 American Home Products Corporation Thiourea for increasing hdl-cholesterol levels, which are useful as anti-atherosclerotic agents
US6255323B1 (en) 1999-04-09 2001-07-03 Shionogi Bioresearch Corp. Cyanoguanidine compounds
GB9908410D0 (en) 1999-04-13 1999-06-09 Pfizer Ltd Pyridines
AU4841700A (en) * 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US6645968B2 (en) 1999-08-03 2003-11-11 Abbott Laboratories Potassium channel openers
CN1705645A (zh) 2002-10-24 2005-12-07 默克专利有限公司 作为raf－激酶抑制剂的亚甲基脲衍生物
US9296697B2 (en) * 2005-08-24 2016-03-29 Abbott Laboratories Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-HT5-receptors
US20070250567A1 (en) * 2006-04-20 2007-10-25 Graham Philip R System and method for controlling a telepresence system
US20110009446A1 (en) * 2008-01-11 2011-01-13 Nektar Therapeutics Oligomer-guanidine class conjugates
HUE029466T2 (en) 2010-12-09 2017-02-28 Radikal Therapeutics Inc Multifunctional nitroxide derivatives and their use
JP2022547083A (ja) * 2019-09-03 2022-11-10 ザルツマン グループ リミテッド グアニジンを含むａｔｐ調節性カリウムチャネル開口薬及びその使用
JP2025066196A (ja) * 2022-03-14 2025-04-23 国立大学法人東北大学 認知機能改善剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3036083A (en) * 1959-05-15 1962-05-22 Ciba Geigy Corp Certain 2-pyridyl lower alkyl guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines

Also Published As

Publication number Publication date
DK145341C (da) 1983-03-28
DK145341B (da) 1982-11-01
YU316275A (en) 1982-02-28
IE42141B1 (en) 1980-06-04
FR2294703A1 (fr) 1976-07-16
DE2557438C2 (en:Method) 1989-01-05
FI753520A7 (en:Method) 1976-06-21
SU683615A3 (ru) 1979-08-30
DE2557438A1 (de) 1976-06-24
JPS6028819B2 (ja) 1985-07-06
USRE31244E (en) 1983-05-17
IT1062213B (it) 1983-09-20
GB1489879A (en) 1977-10-26
IE42141L (en) 1976-06-20
US4057636A (en) 1977-11-08
NL184109B (nl) 1988-11-16
DD122529A5 (en:Method) 1976-10-12
ZA757481B (en) 1977-01-26
LU74071A1 (en:Method) 1976-11-11
SE7514153L (sv) 1976-06-21
FI60560B (fi) 1981-10-30
NL7514852A (nl) 1976-06-22
JPS5186474A (en:Method) 1976-07-29
PH12506A (en) 1979-04-18
ATA936075A (de) 1978-03-15
DE2560633C2 (en:Method) 1988-09-08
BE836885A (fr) 1976-06-21
YU39754B (en) 1985-04-30
SE424637B (sv) 1982-08-02
AT346357B (de) 1978-11-10
FI60560C (fi) 1982-02-10
FR2294703B1 (en:Method) 1980-06-27
AU8712775A (en) 1977-06-09
NL184109C (nl) 1989-04-17
CA1067083A (en) 1979-11-27
CH618429A5 (en:Method) 1980-07-31
DK572975A (da) 1976-06-21

Similar Documents

Publication Publication Date Title
ES443725A1 (es) Metodo para producir un producto hipotensor.
ES405983A1 (es) Procedimiento para la preparacion de derivados de fenileti-lamina fluoralcohilados.
PT83277A (en) Process for preparing thiadiazole oxadiazole thriazole thiadia zin oxadiazin and thriazin carboxilic acids substituted
ES451979A1 (es) Un metodo de preparacion de compuestos antialergicos.
ES409944A1 (es) Procedimiento para la preparacion de derivados de acidos pirrolaceticos y sus sales.
HUT55031A (en) Process for producing esters of 19-norsteroid alcohol derivatives formed with organic acids and salts thereof, as well as pharmaceutical compositions comprising same
ES435361A1 (es) Un metodo para la preparacion de nuevos esteres alcohilicosde aminoacidos.
ES441603A1 (es) Procedimiento para preparar composiciones reguladoras del crecimiento de plantas.
GB966822A (en) New quaternary ammonium derivatives and process for their preparation
ES485835A1 (es) Procedimiento para la preparacion de derivados de acido tienilbenzoico
JPS51115918A (en) Germicides for the porposes withowt medical treatment and method for p reparing them
ES479537A1 (es) Procedimiento de preparacion de esteres bencilidenicos.
GB1531611A (en) (indolin-1-yl)-guanidines
ATE89160T1 (de) Topische zubereitung zur behandlung von alopecie.
JPS51141893A (en) Process for preparing 9-substituted-2-cycloalkylthioadenines.
ES478072A1 (es) Un procedimiento de preparacion de 2-metoxi-benzamidas.
ES301710A1 (es) Procedimiento para la preparación de nuevas 1,2-diaril-4-alquil-3,5-dioxo-pirazolidinas
ES478073A1 (es) Un procedimiento de preparacion de benzamidas.
ATE29253T1 (de) Verfahren zur herstellung von 4-chinolinonen.
ES484086A1 (es) Procedimiento para la preparacion de compuestos de isopropi-lamina
ES434126A1 (es) Procedimiento para la preparacion de derivados aminicos del4-hidroxi-2, 1, 3-benzotiadiazol.
GB1156774A (en) Novel Derivatives of Iodinated Benzylamine and a Process for Producing same
ES217743A1 (es) UN PROCEDIMIENTO PARA LA OBTENCIoN DE NUEVOS DERIVADOS DEL áCIDO BARBITURICO
ATE2222T1 (de) Digoxin-derivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
ES398232A1 (es) Un procedimiento para la preparacion de esteres de acido indenilacetico sustituido.